Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Gallardo

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Laboratory Analysis|December 20, 2023
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndromeGonzalo Blanco, Daniel López-Aventín, Ramon M Pujol, et al.
Journal of the American Academy of Dermatology|June 26, 2013
Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patientsOctavio Servitje, Cristina Muniesa, Yolanda Benavente, et al.
The Journal of Investigative Dermatology|November 19, 2014
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphomaJuan Sandoval, Angel Díaz-Lagares, Rocío Salgado, et al.
JAMA Dermatology|November 14, 2018
Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With BexaroteneIrene Cabello, Pedro Alia, Xavier Pintó, et al.
Blood Advances|April 12, 2022
Sézary syndrome patient-derived models allow drug selection for personalized therapyFernando Gallardo, Evelyn Andrades, Arnau Iglesias, et al.
The Journal of Investigative Dermatology|August 25, 2015
Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis FungoidesFernando Gallardo, Juan Sandoval, Angel Díaz-Lagares, et al.
Dermatologic Therapy|September 29, 2022
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis GroupVicenç Rocamora, Laura Crespi, Marta Ferran, et al.
Annals of Vascular Surgery|December 4, 2025
E-Learning in Vascular Surgery in the Post-COVID-19 Era: The EL-POCO International SurveyNikolaos Patelis, Paulo Eduardo Ocke Reis, Lamisse Karam, et al.
International Journal of Dermatology|May 13, 2024
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis GroupAntonio Sahuquillo-Torralba, Miguel Mansilla-Polo, Conrad Pujol-Marco, et al.
The Lancet. Haematology|June 2, 2022
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trialPablo L Ortiz-Romero, Lidia Maroñas Jiménez, Cristina Muniesa, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Laboratory Analysis|December 20, 2023
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndromeGonzalo Blanco, Daniel López-Aventín, Ramon M Pujol, et al.
Journal of the American Academy of Dermatology|June 26, 2013
Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patientsOctavio Servitje, Cristina Muniesa, Yolanda Benavente, et al.
The Journal of Investigative Dermatology|November 19, 2014
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphomaJuan Sandoval, Angel Díaz-Lagares, Rocío Salgado, et al.
JAMA Dermatology|November 14, 2018
Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With BexaroteneIrene Cabello, Pedro Alia, Xavier Pintó, et al.
Blood Advances|April 12, 2022
Sézary syndrome patient-derived models allow drug selection for personalized therapyFernando Gallardo, Evelyn Andrades, Arnau Iglesias, et al.
The Journal of Investigative Dermatology|August 25, 2015
Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis FungoidesFernando Gallardo, Juan Sandoval, Angel Díaz-Lagares, et al.
Dermatologic Therapy|September 29, 2022
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis GroupVicenç Rocamora, Laura Crespi, Marta Ferran, et al.
Annals of Vascular Surgery|December 4, 2025
E-Learning in Vascular Surgery in the Post-COVID-19 Era: The EL-POCO International SurveyNikolaos Patelis, Paulo Eduardo Ocke Reis, Lamisse Karam, et al.
International Journal of Dermatology|May 13, 2024
Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis GroupAntonio Sahuquillo-Torralba, Miguel Mansilla-Polo, Conrad Pujol-Marco, et al.
The Lancet. Haematology|June 2, 2022
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trialPablo L Ortiz-Romero, Lidia Maroñas Jiménez, Cristina Muniesa, et al.
Pageof 11